Navigation Links
MediGain Announces Release of New Oncology Analytics Solution
Date:1/4/2012

DALLAS, Jan. 4, 2012 /PRNewswire-iReach/ -- MediGain, a national leader in revenue cycle management and financial analytics, today announced the release of OptimOncology, a financial analytics tool that correlates all drug and financial costing for office-based oncology practices.  This unique technology aggregates financial, clinical and drug utilization data and provides measurable results for oncology practices.

"Drug costs are one of the top concerns in all oncology practices.  Reimbursements from the government and private payers continue to decrease.  Our goal is to provide premium care for our patients with the best possible outcomes.  MediGain's solutions help us do just that," stated California oncologist James Berenson, MD. 

In an industry where costs are soaring and payer reimbursements are declining, the prosperity, and sometimes survival, of a practice can depend upon the availability of quality information.  For oncology practices, the OptimOncology solution means physicians have quick access to financial analysis and clinical decision support that has never before been available in an office-based setting. The OptimOncology technology allows them to make more timely and profitable business decisions. 

"We are very excited to have the first true analytics technology for office-based oncology practices," stated Greg Hackney, CEO of MediGain. "This will be a revolutionary milestone in the evolution of oncology practices.  Physicians will be able to quickly understand how the current and future costs and reimbursements will affect their financial performance."

OptimOncology is offered on a web-based analytics platform and supported by client service teams with deep healthcare expertise, allowing the physician to have instant access to the analysis and trends of his practice.

About MediGain:  MediGain is a national Revenue Cycle Management and Financial Analytics company devoted to improving billing, reimbursement collections, and outcomes for healthcare providers and the patients they serve. With over 300 employees, MediGain provides solutions for physician groups, provider networks, and hospitals enabling them to reach their maximum potential through improved operational, financial, and clinical outcomes. 

Media Contact: Corianne Standerfer MediGain, 972-675-7344, corianne.standerfer@medigain.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MediGain
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
2. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
3. Echo Therapeutics Announces $3.6 Million Warrant Exercises
4. Shield HealthCare Announces Caregiver Story Contest Winners
5. PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer
6. Radient Pharmaceuticals Announces Reverse Stock Split
7. ViroPharma Announces Appointment of Julie H. McHugh to Board of Directors
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at J.P. Morgan Healthcare Conference
9. Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code
10. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
11. Cyberonics Announces FDA Approval of Re-Designed AspireHC™ Generator for VNS Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... company focused on the development of a once-daily, ... or NASH, and other liver diseases, today reported ... ended December 31, 2016, and announced new and exciting ... potential direct effect on liver fibrosis. The data ...
(Date:3/23/2017)... , March 23, 2017 ReNeuron ... its CTX cells in chronic stroke patients, despite not meeting ... primary outcome measure, the Action Research Arm Test (ARAT). As ... to a pivotal controlled clinical study in 2017. Beyond CTX, ... (RP) trial in 2017 and Phase I data from its ...
(Date:3/22/2017)... 23, 2017 ReportsnReports.com adds Global ... research report. The global vagus nerve stimulation market analyst ... focus toward minimally invasive VNS procedures. Few years ago, ... developed countries having high standards of healthcare infrastructure. ... ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... ... the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, ... How will the new EU MDR language change the way manufacturers approach ...
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare ... Assurance, at HCCA’s 21st annual Compliance Institute on March 26-28 in National Harbor, ... for all medical chart types with a comprehensive set of features including built-in ...
(Date:3/23/2017)... ... 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy and ... published author Bonetta Rose, a wife, mother and grandmother committed to sharing her many ... Publishing, Bonetta Rose‘s new book presents actual events in the life of her family, ...
(Date:3/23/2017)... ... ... Journey Through Heaven”: the true-life account of a man who faced death and emerged ... for His people. “My Journey Through Heaven” is the creation of published author Earl ... grandchildren living and doing for God as best they can. , Published by Christian ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... existence of God. “A Respectful Response To Atheist Manifesto” is the creation of ... to his wife, Nancy, for sixty years. He holds graduate degrees from Kent ...
Breaking Medicine News(10 mins):